Liquiritin (LIQ) has been shown to inhibit drug-induced apoptosis by increasing Bax and reducing Bcl-2 in cisplatin (DDP)-resistant gastric cancer cells [32]. The gene discussed is BCL2; the disease is gastric cancer.